Phosphate ion
- Generic Name
- Phosphate ion
- Drug Type
- Small Molecule
- Chemical Formula
- O4P
- CAS Number
- 14265-44-2
- Unique Ingredient Identifier
- NK08V8K8HR
Evaluation of the Quality of Life of Patients Requiring Intestinal Cleansing Using Oral Medications to Imaging Procedure by Patient Reported Outcome
- Conditions
- Bowel Preparation
- Interventions
- Drug: polyethylene glycol + Electrolytes
- First Posted Date
- 2015-09-01
- Last Posted Date
- 2015-09-01
- Lead Sponsor
- Fundación Salutia
- Target Recruit Count
- 600
- Registration Number
- NCT02536729
Arterolane-PQP Versus DHA-PQP in Uncomplicated Falciparum Malaria in Eastern Myanmar
Phase 2
Withdrawn
- Conditions
- Artemisinin-resistantUncomplicated Falciparum Malaria
- Interventions
- First Posted Date
- 2015-06-03
- Last Posted Date
- 2015-11-03
- Lead Sponsor
- University of Oxford
- Registration Number
- NCT02461186
Safety and Therapeutic Efficacy of Phosphate Enema (Kleen Enema) in Patients Undergoing Sigmoidoscopy
- First Posted Date
- 2015-03-12
- Last Posted Date
- 2015-03-17
- Lead Sponsor
- Nabiqasim Industries (Pvt) Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT02386904
- Locations
- 🇵🇰
National Institute of Liver and GI diseases, DUHS, Karachi, Sindh, Pakistan
A Prospective Randomized, Double-Blind, Placebo-Controlled Trial Comparing VitroGro® ECM to Placebo in Patients With Venous Leg Ulcers
Phase 2
Withdrawn
- Conditions
- Venous Leg Ulcer
- Interventions
- Drug: VitroGro® ECM
- First Posted Date
- 2013-11-13
- Last Posted Date
- 2017-05-30
- Lead Sponsor
- Tissue Therapies Ltd.
- Registration Number
- NCT01982318
Naproxen Codeine in Arthroscopic Surgery
Phase 4
Completed
- Conditions
- Arthroscopic Meniscus Surgery
- First Posted Date
- 2013-09-30
- Last Posted Date
- 2013-09-30
- Lead Sponsor
- Baskent University
- Target Recruit Count
- 61
- Registration Number
- NCT01952652
- Locations
- 🇹🇷
Baskent University School of Medicine Adana Teaching and Research Hospital, Adana, Turkey
Safety, Tolerability, Pharmacokinetics and Efficacy of ARCO
Phase 4
Completed
- Conditions
- Malaria, FalciparumPlasmodium Falciparum
- Interventions
- Drug: artemisinin/naphthoquine
- First Posted Date
- 2013-08-28
- Last Posted Date
- 2018-03-14
- Lead Sponsor
- Ifakara Health Institute
- Target Recruit Count
- 60
- Registration Number
- NCT01930331
- Locations
- 🇹🇿
Ifakara Health Institute, Bagamoyo, Tanzania
A Trial of Three Types of Enemas Used to Treat Functional Constipation in Children
Not Applicable
Terminated
- Conditions
- Functional Constipation
- Interventions
- First Posted Date
- 2013-04-04
- Last Posted Date
- 2023-11-01
- Lead Sponsor
- Children's Hospital Los Angeles
- Target Recruit Count
- 40
- Registration Number
- NCT01823848
- Locations
- 🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients
Phase 4
Completed
- Conditions
- HyperphosphatemiaCardiovascular EventsHemodialysis
- Interventions
- First Posted Date
- 2012-12-21
- Last Posted Date
- 2014-08-05
- Lead Sponsor
- Chugai Pharma Taiwan
- Target Recruit Count
- 166
- Registration Number
- NCT01755078
Measurement of Gastric Emptying During and After COLOKIT® Intake
- First Posted Date
- 2011-07-20
- Last Posted Date
- 2012-11-29
- Lead Sponsor
- Laboratoires Mayoly Spindler
- Target Recruit Count
- 30
- Registration Number
- NCT01398098
- Locations
- 🇫🇷
Cochin Hospital, Paris, France
A Phase 1 Study of LY2874455 in Participants With Advanced Cancer
- First Posted Date
- 2010-09-30
- Last Posted Date
- 2019-06-12
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 94
- Registration Number
- NCT01212107
- Locations
- 🇰🇷
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath